SCHEMBL6929185

SCHEMBL6929185

CCCOc1ccc(C=CC(=O)N2CCOCC2)cc1C1NC(=O)c2c(C)n[nH]c2N1CCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.47
RAB9A P51151 8/20 0.47
SMN1; SMN2 Q16637 4/20 0.41
KMT2A Q03164 4/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
MEN1 O00255 3/20 0.41
APP P05067 2/20 0.41
TRPV1 Q8NER1 1/20 0.40
TDP1 Q9NUW8 2/20 0.37
ALDH1A1 P00352 3/20 0.36
MAOB P27338 1/20 0.36
LMNA P02545 1/20 0.35
MAPK1 P28482 1/20 0.35
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6933267 0.88 NPC1 (0.47) NPC1RAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL8769700 0.77 MAPT (0.39) NPC1RAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL7132309 0.74 KDM4E (0.45) SMN1; SMN2KMT2AKDM4EHPGDMEN1
SCHEMBL8769913 0.71 KDM4E (0.34) SMN1; SMN2KMT2AKDM4EHPGDMEN1
SCHEMBL6930144 0.71 RAB9A (0.38) NPC1RAB9AKMT2AKDM4EHPGD
SCHEMBL7795495 0.69 NPC1 (0.48) NPC1RAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL6929189 0.69 NPC1 (0.46) NPC1RAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL3835865 0.68 PDE5A (0.58)
SCHEMBL7350274 0.68 PDE5A (0.58)
SCHEMBL6932442 0.67 MAPT (0.47) SMN1; SMN2KDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1365806-A2 USE OF NO ACTTIVATORS FOR TREATMENT AND PREVENTION OF GASTROINTESTINAL DISORDERS JOHNS HOPKINS UNIVERSITY (US) 2003-12-03 EP claimed
WO-2001078781-A9 METHODS FOR PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS UNIV JOHNS HOPKINS (US) 2002-07-25 WO claimed
WO-2001078781-A2 METHODS FOR PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS JOHNS HOPKINS UNIVERSITY (US) 2001-10-25 WO claimed
EP-1365806-A2 USE OF NO ACTTIVATORS FOR TREATMENT AND PREVENTION OF GASTROINTESTINAL DISORDERS JOHNS HOPKINS UNIVERSITY (US) 2003-12-03 EP disclosed
WO-2001078781-A9 METHODS FOR PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS UNIV JOHNS HOPKINS (US) 2002-07-25 WO disclosed
WO-2001078781-A2 METHODS FOR PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS JOHNS HOPKINS UNIVERSITY (US) 2001-10-25 WO disclosed